​​​​​​​​​​​​​​​​​​​​​​​​​​​​The Prescription Drug Affordability Board is an independent unit of state government tasked with protecting Marylanders and the Maryland health care system from the high costs of prescription drug products.

​​

Section1

​Announcements

  • Upcoming Meeting: Prescription Drug Affordability Board Stakeholder Council (PDASC) Meeting, February 24, 2025 at 2:00PM. Please visit the PDASC page​ for more information. 
  • Comments on Proposed Regulations are due February 10, 2025. Please visit the regulations page​ to see the current Notice of Proposed Regulations or scroll below. 

Section2

NOTICE OF ​​​​PROPOSED ACTION:

The Maryland Prescription Drug Affordability Board proposes to:
(1) Amend Regulation .01 under COMAR 14.01.01 General Provisions;
(2) Adopt new Regulation .06 under COMAR 14.01.01 General Provisions;
(3) Adopt new Regulations .01—.09 under a new chapter, COMAR 14.01.05 Policy Review, Final Action, Upper Payment Limits.

The text of the proposed amendments and regulations are available in the January 10, 2025 edition of the Maryland Register located here.
Comments may be sent to:
Christina Shaklee, Health Policy Analyst Advanced
Maryland Prescription Drug Affordability Board
16900 Science Drive, Suite 112-114 
Bowie, MD 20715;
or call 410-703-7015;
or email to christina.shaklee1@maryland.gov​

 Comments will be accepted through February 10, 2025. ​



Section3

Section5